Loading insider details...
Beta
Latest Form 4 (Jun 18, 2026): Grant/Award of 31,675 BBOT shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 18, 2026 | BridgeBio Oncology Therapeutics, Inc. (BBOT) | Grant/Award | 31,675 | n/a |
| Jun 10, 2026 | Tectonic Therapeutic, Inc. (TECX) | Grant/Award | 10,200 | n/a |
| Aug 28, 2025 | BridgeBio Oncology Therapeutics, Inc. (BBOT) | Grant/Award | 52,269 | n/a |
| Jun 11, 2025 | Tectonic Therapeutic, Inc. (TECX) | Grant/Award | 10,200 | n/a |
| Aug 20, 2024 | Morphic Holding, Inc. (MORF) | Tender of Shares | 42,460 | n/a |
| Jul 10, 2024 | Morphic Holding, Inc. (MORF) | Exercise/Conversion | 21,582 | $93.1K |
| Jun 24, 2024 | Tectonic Therapeutic, Inc. (TECX) | Grant/Award | 3,037 | n/a |
| Jan 17, 2024 | Morphic Holding, Inc. (MORF) | Exercise/Conversion | 29,500 | n/a |